Danny - i think that's one of the issues with Phylogica & the reason it continues trading where its despite very encouraging developments, from the people i've spoken with alot comes down to the guidance as delivered by the company over the past few years i guess as we've also discussed here maybe more of a shank than a positive push on the company. No investors like companies over promising & under delivering but it has been the case here with number over deals targeted a year & the calls for cash sustainability that have previously been made with dates always pushed further back & yet in past interviews always maintaing they remain on track with guidance even when it has looked unlikely to anyone on the outside & in turn it has not been met. I think it's best to tone down the extremely bullish forecasts by management & then suprise the market by delivering better than expected results & outcomes as opposed to not meeting the guidance delivered & therefore expected by market.
Don't get me wrong I love hearing the bullish forecasts belted out by management but if they don't deliver then it scars the whole purpose of marketing the company to investors.
Anyway 2012 we'll see what delivers.
PYC Price at posting:
4.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)